跳至主要内容
临床试验/NCT02185092
NCT02185092撤回不适用

Probiotic Use in Patients With Prior COPD Exacerbation

University of Oklahoma2 个研究点 分布在 1 个国家开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
COPD exacerbations

研究概览

简要总结

The purpose of the study is to examine the hypothesis test that probiotics will reduce the frequency of exacerbation in patients with COPD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted to OUMC or VAMC with a COPD exacerbation and pneumonia with underlying COPD will be eligible and screened.
  • Patients seen in VA Chest Medicine clinic, OU Physicians clinic and Pulmonary fellows clinic at PPOB who have had a COPD exacerbation within the last year.
  • Patients over age 18
  • Patients who have a pulmonary function test (PFT) showing COPD within 1 year of enrollment in the study or if the treating physician plans to obtain PFT as part of the patient's care plan.
  • Patients will be considered to have a diagnosis of COPD if they have a FEV1 of less than 80% of predicted and a FVC/FEV1 ratio of less than 0.70 (as defined by GOLD criteria).

排除标准

  • Patients with less than one year of life expectancy from a concomitant diagnosis
  • Any GI motility disorders or previous bowel resection surgery (short gut syndrome)
  • Any patients with decreased immune function or on medication that may decrease immune function (other than low dose steroid or steroid taper).
  • Patients admitted within the last one year with a diagnosis of pancreatitis
  • Patients unable to give consent will not be included in the study.
  • Patients unable to sign consent
  • Patients already on azithromycin daily for COPD exacerbations
  • Patients under department of corrections custody.

结局指标

主要结局

COPD exacerbations

时间窗: 1 year

The primary end point will be the number of COPD exacerbations.

次要结局

  • Antibiotic Use(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验